Short posterior ciliary artery, central retinal artery, and choroidal hemodynamics in brimonidine-treated primary open-angle glaucoma patients

American Journal of Ophthalmology

Volumn 136, Issue 6, 2003, Pages 1038-1048

  Schmidt, Karl Georg ^a   Klingmüller, Volker ^b   Gouveia, Scott M ^c   Osborne, Neville N ^c   Pillunat, Lutz E ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRIMONIDINE;

ADULT; ARTERY PERFUSION; ARTICLE; CHOROID; CILIARY ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EYE BLOOD FLOW; FEMALE; HEART RATE; HEMODYNAMICS; HUMAN; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA ARTERY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 0344873221     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(03)00631-7     Document Type: Article

References (56)

1. Pillunat L.E., Stodtmeister R., Marquardt R., Mattern A. Ocular perfusion pressures in different types of glaucoma. Int Ophthalmol. 13:1989;37-42.
2. Flammer J., Haefliger I.O., Orgül S., Resink T. Vascular dysregulation A principal risk factor for glaucomatous damage? J Glaucoma. 8:1999;212-219.
3. Flammer J., Guthauser U. Behandlung chorioidaler Vasospasmen mit Kalziumantagonisten. Klin Monatsbl Augenheilkd. 190:1987;299-300.
4. Gasser P., Flammer J. Blood-cell velocity in the nailfold capillaries of patients with normal-tension or high-tension glaucoma and of healthy controls. Am J Ophthalmol. 111:1991;585-588.
5. Gaspar A.Z., Flammer J., Hendrickson P. Influence of nifedipine on the visual fields of patients with optic nerve head diseases. Eur J Ophthalmol. 4:1994;24-28.
6. Schmidt KG, v. Rückmann A, Mittag TW. Erhöhte chorioidale Perfusion bei okulärer Hypertension - ein Schutzmechanismus? In: Schmidt KG, editor. Glaukom - Aktuelle Diagnostik und Therapie. München: Ad manum medici, 1998:57-70.
7. Schmidt K.G. Antiglaukomatosa und choroidale Perfusion bei primärem und experimentell induziertem Offenwinkelglaukom. Schmidt K.G., Pillunat L.E. Fortbildung Glaukom, Bd 1, Perfusion und Pharmakologie. 1999;39-50 Enke, Stuttgart.
8. Schmidt K.G., Mittag T.W., Pavlovic S., Hessemer V. Influence of physical exercise and nifedipine on ocular pulse amplitude. Graefes Arch Clin Exp Ophthalmol. 234:1996;527-532.
9. Schmidt K.G., v. Rückmann A., Mittag T.W., Hessemer V., Pillunat L.E. Reduced ocular pulse amplitude in low tension glaucoma is independent of vasospasm. Eye. 11:1997;485-488.
10. Schmidt K.G., Klingmüller V., v. Rückmann A., Koch B. Retrobulbäre und chorioidale Hämodynamik bei Hochdruck - und Normaldruckglaukom. Schmidt K.G., Pillunat L.E. Fortbildung Glaukom, Bd 3. 2000;103-114 Enke, Stuttgart.
11. Osborne N.N., Ugarte M., Chao M., et al. Neuroprotection in relation to retinal ischaemia and relevance to glaucoma. Surv Ophthalmol. 43:(Suppl):1999;S102-S129.
12. Hayreh S.S. The role of age and cardiovascular disease in glaucomatous optic neuropathy. Surv Ophthalmol. 43:(Suppl):1999;S27-S42.
13. Osborne N.N., Chidlow G., Nash M.S., Wood J.P. The potential of neuroprotection in glaucoma treatment. Curr Opin Ophthalmol. 10:1999;82-92.
14. Melena J., Chidlow G., Osborne N.N. Blockade of voltage-sensitive Na(+) channels by the 5-HT(1A) receptor agonist 8-OH-DPAT possible significance for neuroprotection . Eur J Pharmacol. 406:2000;319-324.
15. Osborne N.N., Melena J., Chidlow G., Wood J.P. A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head possible implication for the treatment of glaucoma . Br J Ophthalmol. 85:2001;1252-1259.
16. Fechtner R.D., Weinreb R.N. Mechanisms of optic nerve damage in primary open-angle glaucoma. Surv Ophthalmol. 39:1994;23-42.
17. Kolker A.E. Visual prognosis in advanced glaucoma A comparison of medical and surgical therapy for retention of vision in 101 eyes with advanced glaucoma . Trans Am Ophthalmol Soc. 75:1977;539-555.
18. Quigley H.A., Maumenee A.E. Longterm followup of treated open-angle glaucoma. Am J Ophthalmol. 87:1979;519-525.
19. Greenfield D.S., Liebmann J.M., Ritch R. Brimonidine A new alpha2-adrenoreceptor agonist for glaucoma treatment . J Glaucoma. 6:1997;250-258.
20. Toris C.B., Camras C.B., Yablonski M.E. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. Am J Ophthalmol. 128:1999;8-14.
21. Kent A.R., Nussdorf J.D., David R., Tyson F., Small D., Fellows D. Vitreous concentration of topically applied brimonidine tartrate 0.2%. Ophthalmology. 108:2001;784-787.
22. Javitt J.C., Schiffman R.M. Clinical success and quality of life with brimonidine 0.2% or timolol 0.5% used twice daily in glaucoma or ocular hypertension A randomized clinical trial: Brimonidine outcomes study group I . J Glaucoma. 9:2000;224-234.
23. Cantor L.B. The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use. Expert Opin Pharmacother. 1:2000;815-834.
24. Errasti A.E., Velo M.P., Torres R.M., Sardi S.P., Rothlin R.P. Characterization of alpha-1-adrenoceptor subtypes mediating vasoconstriction in human umbilical vein. Br J Pharmacol. 126:1999;437-442.
25. Aleixandre A., Lopez-Miranda V., Ortega A. Alpha-vascular responses after short-term and long-term inhibition of nitric oxide synthesis. J Cardiovasc Pharmacol. 37:2001;133-142.
26. Carlsson A.M., Chauhan B.C., Lee A.A., LeBlanc R.P. The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension. Am J Ophthalmol. 129:2000;297-301.
27. Lachkar Y., Migdal C., Dhanjil S. Effect of brimonidine tartrate on ocular hemodynamic measurements. Arch Ophthalmol. 116:1998;1591-1594.
28. Bhandari A., Cioffi G.A., Van-Buskirk E.M., Orgul S., Wang L. Effect of brimonidine on optic nerve blood flow in rabbits. Am J Ophthalmol. 128:1999;601-605.
29. Nordlund J.R., Pasquale L.R., Robin A.L., et al. The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine. Arch Ophthalmol. 113:1995;77-83.
30. Martinez A., Gonzalez F., Capeans C., et al. Dorzolamide effects on ocular blood flow. Invest Opthalmol Vis Sci. 40:1999;1270-1275.
31. Kitazawa Y., Shirai H., Go F.J. The effect of a Ca++ antagonist on visual field in low tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 227:1989;408-412.
32. Netland P.A., Chaturvedi N., Dreyer E.B. Calcium channel blockers in the management of low tension and open-angle glaucoma. Am J Ophthalmol. 115:1993;608-613.
33. Baxter G.M., Williamson T.H. Color Doppler imaging of the eye Normal ranges, reproducibility and observer variation . J Ultrasound Med. 14:1995;91-96.
34. Lieb W.E., Cohen S.M., Merton D.A., Shields J.A., Mitchell D.C., Goldberg B.B. Color Doppler imaging of the eye and orbit Technique and normal vascular anatomy . Arch Ophthalmol. 109:1991;527-531.
35. Langham M.E., To'Mey K.F. A clinical procedure for the measurements of the ocular pulse-pressure relationship and ophthalmic arterial pressure. Exp Eye Res. 27:1978;17-25.
36. Alm A. Physiologie der okulären Durchblutung. Stodtmeister R., Christ T.h, Pillunat L.E., Ulrich W.D. Okuläre Durchblutungsstörungen. 1987;9-17 Enke, Stuttgart.
37. Williamson T.H., Harris A. Color Doppler ultrasound imaging of the eye and orbit. Surv Ophthalmol. 40:1996;255-267.
38. Butt Z. Reproducibility of pulsatile ocular blood flow measurement. J Glauc. 4:1995;214-218.
39. Chidlow G., Nash M.S., Crowhurst C., Bron A.J., Osborne N.N. The ocular blood flow tonometer A new instrument for the measurement of intraocular pressure in rabbits . Exp Eye Res. 63:1996;463-469.
40. Schmidt K.G. Basic principle of the OBF-System. Pillunat L.E., Harris A., Anderson D.R., Greve E.L. Current Concepts on Ocular Blood Flow in Glaucoma. 1999;75-95 Kugler Publications, The Hague, the Netherlands.
41. Schmidt K.G., v. Rückmann A., Pillunat L.E. Dorzolamide increases ocular pulse amplitude in high tension primary open angle glaucoma. Brit J Ophthalmol. 82:1998;758-762.
42. Langham M.E., McHenry M. The prevention of visual loss by ocular hypotensive drugs. Invest Ophthalmol Vis Sci. 36:(Suppl):1995;966.
43. Kitazawa Y., Shirai H., Go F.J. The effect of a Ca++ antagonist on visual field in low tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 227:1989;408-412.
44. Netland P.A., Chaturvedi N., Dreyer E.B. Calcium channel blockers in the management of low tension and open-angle glaucoma. Am J Ophthalmol. 115:1993;608-613.
45. Costa V.P., Kuzniec S., Molnar L.J., Cerri G.G., Puech Leao P., Carvalho C.A. Collateral blood supply through the ophthalmic artery A steal phenomenon analyzed by color Doppler imaging . Ophthalmology. 105:1998;689-693.
46. Schmidt K.G., Klingmüller V., Auch D., von Rückmann A. Retrobulbar perfusion, ocular pulse amplitude, and endothelin-1 in high tension open angle glaucoma patients on unoprostone and latanoprost. Ophthalmic Res. 32:(Suppl):2000;222.
47. Schmidt K.G., Klingmüller V., v. Rückmann A., Pillunat L.E. Short posterior ciliary and central retinal artery perfusion in high tension open angle glaucoma patients on timolol and dorzolamide. Invest Ophthalmol Vis Sci. 41:(Suppl):2000;2940.
48. Osborne N.N., DeSantis L., Bae J.H., et al. Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina. Exp Eye Res. 9:1999;331-342.
49. Yu D.Y., Su E.N., Cringle S.J., Alder V.A., Yu P.K., Desantis L. Effect of betaxolol, timolol and nimodipine on human and pig retinal arterioles. Exp Eye Res. 67:1998;73-81.
50. Geroski D.H., Edelhauser H.F. Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci. 41:2000;961-964.
51. Matsuo T., Cynader M.S. Localization of alpha-2 adrenergic receptors in the human eye. Ophthalmic Res. 24:1992;213-219.
52. Bylund D.B., Iversen L.J., Matulka W.J., Chacko D.M. Characterization of alpha-2D adrenergic receptor subtypes in bovine ocular tissue homogenates. J Pharmacol Exp Ther. 281:1997;1171-1177.
53. Hoste A.M., Boehls P.J., Andries L.J., Brutsaert D.L., De Laey J.J. Effects of beta-antagonists on contraction of bovine retinal microarteries in vitro. Invest Ophthalmol Vis Sci. 31:1990;1231-1237.
54. Nielsen P.J., Nyborg N.C. Adrenergic responses in isolated bovine retinal resistance arteries. Int Ophthalmol. 13:1989;103-107.
55. Mittag T.W., Serle J., Schumer R., et al. Studies of the ocular pulse in primates. Surv Ophthalmol. 38:(Suppl):1994;183-190.
56. Donello J.E., Padillo E.U., Webster M.L., Wheeler L.A., Gil D.W. alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia. J Pharmacol Exp Ther. 296:2001;216-223.